Alan Lotvin - Aug 3, 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Signature
/s/ Alan M. Lotvin
Stock symbol
CVS
Transactions as of
Aug 3, 2022
Transactions value $
-$5,946,422
Form type
4
Date filed
8/5/2022, 04:50 PM
Previous filing
Jul 13, 2022
Next filing
Jul 3, 2023

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Options Exercise $0 -70.4K -50% $0.00 70.4K Aug 3, 2022 Common Stock 70.4K $58.34 Direct F2, F3
transaction CVS Stock Option Options Exercise $0 -50.5K -71.43% $0.00 20.2K Aug 3, 2022 Common Stock 50.5K $54.19 Direct F4
transaction CVS Stock Option Options Exercise $0 -22.5K -100% $0.00* 0 Aug 4, 2022 Common Stock 22.5K $62.21 Direct F5
holding CVS Phantom Stock Credits 554 Aug 3, 2022 Common Stock 554 $1.00 Direct F6, F7
holding CVS Stock Option 27.4K Aug 3, 2022 Common Stock 27.4K $104.82 Direct F8
holding CVS Stock Option 32.9K Aug 3, 2022 Common Stock 32.9K $78.05 Direct F9
holding CVS Stock Option 121K Aug 3, 2022 Common Stock 121K $74.30 Direct F10
holding CVS Stock Option 78K Aug 3, 2022 Common Stock 78K $101.09 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales were effected pursuant to a Rule 10b5-1 plan.
F2 The number of shares subject to the option were calculated using a 30-day average price.
F3 Option became exercisable in four equal annual installments, commencing 4/1/2021.
F4 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F5 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F6 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F7 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F8 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F9 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F10 Option became exercisable in four equal annual installments, commencing 4/1/2022.
F11 Option becomes exercisable in four equal annual installments, commencing 4/1/2023.